


| Key | % Net Assets | 
|---|---|
|  Vodafone Group | 8.7% | 
|  BP | 7.5% | 
|  Royal Dutch Shell B | 6.5% | 
|  Glaxosmithkline | 6.1% | 
|  Other | 71.2% | 
| Name | % Net Assets | 
|---|---|
| Vodafone Group | 8.7% | 
| BP | 7.5% | 
| Royal Dutch Shell B | 6.5% | 
| Glaxosmithkline | 6.1% | 
| Rio Tinto | 5.9% | 
| HSBC Hldgs | 4.8% | 
| BT Group | 3.6% | 
| Astrazeneca | 3.1% | 
| Reuters Group | 3.0% | 
| Legal & General Group | 2.5% | 
No asset data available.
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 01/11/1984 | 
|---|---|
| Fund Manager | Tim Ress | 
| TER | 3.26 (30-Apr-2012) | 
| Minimum Investment | |
|---|---|
| Initial | 2000 | 
| Additional | 1,000 | 
| Savings | 100 | 
| Charges | |
|---|---|
| Initial | 4.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.06 | 
You are here: research